CL2010000497A1 -
Use of indole derived compounds for the treatment of visceral pain; specific compounds derived from indole; method of preparing a compound; Pharmaceutical composition and use for the treatment of a condition caused by the action of us.
- Google Patents
Use of indole derived compounds for the treatment of visceral pain; specific compounds derived from indole; method of preparing a compound; Pharmaceutical composition and use for the treatment of a condition caused by the action of us.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filedlitigationCriticalhttps://patents.darts-ip.com/?family=66221219&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2010000497(A1)"Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Neuraxon IncfiledCriticalNeuraxon Inc
Priority to CL2010000497ApriorityCriticalpatent/CL2010000497A1/en
Publication of CL2010000497A1publicationCriticalpatent/CL2010000497A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Método para el tratamiento del dolor visceral que comprende un compuesto derivado de indol; compuestos específicos; procedimiento de preparación de un compuesto; composición farmacéutica.Method for the treatment of visceral pain comprising a compound derived from indole; specific compounds; method of preparing a compound; pharmaceutical composition
CL2010000497A2010-05-142010-05-14
Use of indole derived compounds for the treatment of visceral pain; specific compounds derived from indole; method of preparing a compound; Pharmaceutical composition and use for the treatment of a condition caused by the action of us.
CL2010000497A1
(en)
Use of indole derived compounds for the treatment of visceral pain; specific compounds derived from indole; method of preparing a compound; Pharmaceutical composition and use for the treatment of a condition caused by the action of us.
Use of indole derived compounds for the treatment of visceral pain; specific compounds derived from indole; method of preparing a compound; Pharmaceutical composition and use for the treatment of a condition caused by the action of us.
Use of indole derived compounds for the treatment of visceral pain; specific compounds derived from indole; method of preparing a compound; Pharmaceutical composition and use for the treatment of a condition caused by the action of us.
Compounds derived from amino-pyrimidines; pharmaceutical compositions comprising them; and its use for the treatment of a disease selected condition of neuromuscular disorders, amyotrophic lateral sclerosis, myasthenia gravis, among others.
Compounds derived from amino-pyridazines; pharmaceutical compositions comprising them; and its use for the treatment of a disease selected condition of neuromuscular disorders, amyotrophic lateral sclerosis, myasthenia gravis, among others.
Compounds derived from substituted pyrrolidine-2-carboxamides; mdm2-p53 interaction inhibitors; pharmaceutical composition; and its use for the treatment of cancer, particularly solid tumors.
Compounds derived from 2-oxo-piperidine and 1,1-dioxide-thiazine, mdm2 inhibitors; pharmaceutical composition that includes them; and its use for the treatment of cancer.
A method of treating a subject comprising administering optionally deuterated n-ethyl-n-phenyl1,2-dihydroxy-4-hodroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide, for the treatment of a disease autoimmune; a mixture thereof; Pharmaceutical composition and its preparation process.
Spiro-derived heterocyclic compounds of cyclohexane, hsl inhibitors; preparation procedure; pharmaceutical composition comprising them; use of the compound for the treatment of diabetes, metabolic syndrome, dyslipidemia, atherosclerosis or obesity.
Compounds derived from benzyl sulfonamide, mogat-2 inhibitors; crystalline compound; pharmaceutical composition; and its use in the treatment of hypertriglyceridemia.
Compounds derived from 3- (1 h-pyrrol-2-yl-methyl) -1, 3-dihydro-2h-indol-2-one; procedures for the preparation of said compounds; pharmaceutical composition and pharmaceutical combination comprising them; and its use for the treatment of cancer.